Abstract OBJECTIVE: To study the value of basal serum gonadotropin levels in the diagnosis of precocious puberty (PP) in girls. METHODS: A total of 77 girls with PP were divided into central PP (CPP) (n=45) and isolated premature thelarche (IPT) groups (n=32) based on the results of gonadotropin releasing hormone (GnRH) stimulation test, which was considered the gold standard for diagnosis of PP. The two groups were compared with respect to basal serum luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels and LH/FSH ratio. The receiver operating characteristic (ROC) curve was used to analyze the accuracy of basal LH and FSH levels and LH/FSH ratio in the diagnosis of PP. RESULTS: The basal serum LH and FSH levels and LH/FSH ratio in the CPP group were significantly higher than in the IPT group (P<0.01). The basal serum LH level was positively correlated with peak LH level in the GnRH stimulation test in both groups. For diagnosis of CPP, the area under the ROC curve (AUC) for basal serum LH level was larger than for basal serum FSH level and LH/FSH ratio (P<0.05), and there was no significant difference in the AUC value between basal serum FSH level and LH/FSH ratio. When the basal serum LH level was 0.62 IU/L, there was a maximum Youden index (0.684), with 77.8% sensitivity and 90.6% specificity. When the basal serum LH level reached 1.5 IU/L, the sensitivity decreased to 31.1%, but with the highest specificity (100%). CONCLUSIONS: Basal serum LH level is superior to LH/FSH ratio and basal serum FSH level in the diagnosis of CPP, and can be used for preliminary diagnosis of PP in girls in the out-patient department, but there is some misdiagnosis and missed diagnosis. When basal serum LH level is higher than 1.5 IU/L the diagnosis of CPP can be confirmed in combination with clinical manifestation, without the need for an additional GnRH stimulation test.
［1］Ma HM, Du ML, Luo XP, Chen SK, Liu L, Chen RM, et al. Onset of breast and pubic hair development and menses in urban chinese girls［J］. Pediatrics, 2009, 124(2): e269-e277.
［2］Mogensen SS, Aksglaede L, Mouritsen A, Sorensen K, Main KM, Gideon P, et al. Diagnostic work-up of 449 consecutive girls who were referred to be evaluated for precocious puberty［J］. J Clin Endocrinol Metab, 2011, 96(5): 1393-1401.
［3］Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR; ESPE-LWPES GnRH Analogs Consensus Conference Group, et al. Consensus statement on the use of gonadotropin-releasing hormone analogs in children［J］. Pediatrics, 2009, 123(4): e752-e762.
［4］Lee PA. Central precocious puberty. An overview of diagnosis, treatment, and outcome［J］. Endocrinol Metab Clin North Am, 1999, 28(4): 901-918.
［5］Demirbilek H, Alikasifoglu A, Gonc NE, Ozon A, Kandemir N. Assessment of gonadotrophin suppression in girls treated with GnRH analogue for central precocious puberty; validity of single luteinizing hormone measurement after leuprolide acetate injection［J］. Clin Endocrinol (Oxf), 2012, 76(1): 126-130.
［6］Partsch CJ, Heger S, Sippell WG. Management and outcome of central precocious puberty［J］. Clin Endocrinol (Oxf), 2002, 56(2): 129-148.
［7］Poomthavorn P, Khlairit P, Mahachoklertwattana P. Subcutaneous gonadotropin-releasing hormone agonist (triptorelin) test for diagnosing precocious puberty［J］. Horm Res, 2009, 72(2): 114-119.
［8］Houk CP, Kunselman AR, Lee PA. Adequacy of a single unstimulated luteinizing hormone level to diagnose central precocious puberty in girls［J］. Pediatrics, 2009, 123(6): e1059-e1063.
［9］Neely EK, Wilson DM, Lee PA, Stene M, Hintz RL. Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty［J］. J Pediatr, 1995, 127(1): 47-52.
［10］Pandian MR, Odell WD, Carlton E, Fisher DA. Development of third-generation immunochemiluminometric assays of follitropin and lutropin and clinical application in determining pediatric reference ranges［J］. Clin Chem, 1993, 39(9): 1815-1819.
［13］Resende EA, Lara BH, Reis JD, Ferreira BP, Pereira GA, Borges MF. Assessment of basal and gonadotropin-releasing hormone-stimulated gonadotropins by immunochemiluminometric and immunofluorometric assays in normal children［J］. J Clin Endocrinol Metab, 2007, 92(4): 1424-1429.
［14］Berberoglu M. Precocious puberty and normal variant puberty: definition, etiology, diagnosis and current management［J］. J Clin Res Pediatr Endocrinol, 2009, 1(4): 164-174.
［15］Kandemir N, Demirbilek H, Ozon ZA, Gonc N, Alikasifoglu A. GnRH stimulation test in precocious puberty: single sample is adequate for diagnosis and dose adjustment［J］. J Clin Res Pediatr Endocrinol, 2011, 3(1): 12-17.
